These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15502522)

  • 1. C-reactive protein elevation and the risk of colorectal cancer.
    Saddler D; Greenwald B
    Gastroenterol Nurs; 2004; 27(5):246-7. PubMed ID: 15502522
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
    Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
    Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and risk for colorectal cancer.
    Mascitelli L; Pezzetta F
    Ann Intern Med; 2005 Oct; 143(7):544; author reply 544. PubMed ID: 16204172
    [No Abstract]   [Full Text] [Related]  

  • 4. Is C-reactive protein an inflammation opsonin that signals colon cancer risk?
    Pasche B; Serhan CN
    JAMA; 2004 Feb; 291(5):623-4. PubMed ID: 14762043
    [No Abstract]   [Full Text] [Related]  

  • 5. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
    Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
    Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summaries for patients. Can a blood test help predict who is at risk for colorectal cancer?
    Ann Intern Med; 2005 Mar; 142(6):I79. PubMed ID: 15767616
    [No Abstract]   [Full Text] [Related]  

  • 7. High sensitivity C-reactive protein: can it predict cardiovascular risk in postmenopausal women?
    Drown DJ
    Prog Cardiovasc Nurs; 2000; 15(4):152-3. PubMed ID: 11098530
    [No Abstract]   [Full Text] [Related]  

  • 8. Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer.
    Nozoe T; Matsumata T; Kitamura M; Sugimachi K
    Am J Surg; 1998 Oct; 176(4):335-8. PubMed ID: 9817250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening methods for colorectal cancer can be improved].
    Rasmussen L; Jørgensen LN; Madsen MR; Vilandt J; Klærke M; Andersen J; Nielsen KT; Khalid A; Laurberg S; Andersen CL; Christensen IJ; Brünner N; Nielsen HJ
    Ugeskr Laeger; 2014 Mar; 176(11B):. PubMed ID: 25350810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
    Zhang SM; Buring JE; Lee IM; Cook NR; Ridker PM
    Ann Intern Med; 2005 Mar; 142(6):425-32. PubMed ID: 15767620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients.
    Groblewska M; Mroczko B; Wereszczyńska-Siemiatkowska U; Kedra B; Lukaszewicz M; Baniukiewicz A; Szmitkowski M
    Clin Chem Lab Med; 2008; 46(10):1423-8. PubMed ID: 18844497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
    PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
    Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
    Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
    Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
    World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical evaluation demonstrated importance of validating biomarkers for early detection of cancer in screening settings to limit the number of false-positive findings.
    Chen H; Knebel P; Brenner H
    J Clin Epidemiol; 2016 Jul; 75():108-14. PubMed ID: 26836253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New blood test to measure heart attack risk: C-reactive protein.
    Duffy JR; Salerno M
    J Cardiovasc Nurs; 2004; 19(6):425-9. PubMed ID: 15529066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Values of Postoperative and Dynamic Changes of Inflammation Indexes in Survival of Patients with Resected Colorectal Cancer.
    Zhou ZQ; Pang S; Yu XC; Xue Q; Jiang HY; Liang XJ; Liu L
    Curr Med Sci; 2018 Oct; 38(5):798-808. PubMed ID: 30341514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein and the risk of incident colorectal cancer.
    Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
    JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is C-reactive protein useful in prognostication for colorectal cancer? A systematic review.
    Pathak S; Nunes QM; Daniels IR; Smart NJ
    Colorectal Dis; 2014 Oct; 16(10):769-76. PubMed ID: 25039573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.